Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
Condition(s):LeishmaniasisLast Updated:March 15, 2022Completed
Hide Studies Not Open or Pending
Condition(s):LeishmaniasisLast Updated:March 15, 2022Completed
Condition(s):Visceral LeishmaniasisLast Updated:April 3, 2009Completed
Condition(s):Invasive Pulmonary Aspergillosis; Lymphoblastic Leukaemia; Myeloblastic Leukaemia; Lymphoblastic Leukemia; Myeloblastic LeukemiaLast Updated:March 29, 2018Completed
Condition(s):Visceral LeishmaniasisLast Updated:June 22, 2011Completed
Condition(s):Cryptococcal MeningitisLast Updated:May 12, 2014Unknown status
Condition(s):Visceral LeishmaniasisLast Updated:August 26, 2019Completed
Condition(s):Cryptococcal MeningitisLast Updated:February 22, 2016Unknown status
Condition(s):Neutropenia and FeverLast Updated:November 5, 2021Unknown status
Condition(s):Invasive Fungal DiseaseLast Updated:May 7, 2015Completed
Condition(s):Fungal InfectionLast Updated:December 8, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.